Review
Open access
Aug 2026
Circulating tumor DNA dynamics and mutational profiles as indicators in neoadjuvant chemoimmunotherapy for resectable or borderline resectable non-small cell lung cancer
Longitudinal ctDNA assessment identified high-risk subgroups in neoadjuvant NSCLC, particularly by refining prognosis in heterogeneous SD populations, and an exploratory gene-based mutational signature provided potential molecular risk stratification.
Wenxin Jiang, Si-Yu Lei, Sijie Liu et al.
· Respiratory Research · 0 citations